Month: January 2017

Stock Analysts

Methanex Touches Fresh 52-Week High: What’s Driving It?

January 9, 2017 0

Shares of Methanex Corporation MEOH scaled a fresh 52-week high of $47.43 on Jan 6, before retracing to close the day at $47.15. Methanex has a market cap of roughly $4.2 billion and average volume of shares traded in the last three months is around 629.9K. The company has an expected long-term EPS growth of around 15%. […]

Stock Analysts

Teva Falls on Disappointing 2017 Sales & Earnings Guidance

January 9, 2017 0

Teva Pharmaceutical Industries Ltd. TEVA provided a weaker-than-expected sales and earnings guidance for 2017 seeing that its blockbuster multiple sclerosis drug, Copaxone, is reeling under competitive pressures. Following the announcement, shares of the Israeli generic pharmaceuticals company declined almost 8% on Friday […]

Stock Analysts

IBM Watson to Power Panasonic’s Cognitive Infotainment

January 9, 2017 0

Shares of International Business Machines Corporation IBM have underperformed the broader Zacks Computer Integrated Systems industry over the last 12 months. While the industry generated a return of 38.4%, the stock gained 27.3%. The underperformance of the stock could be attributed to the ongoing and heavily time-consuming business model transition to the cloud […]

Momentum Stocks

Bull of the Day: EMCORE (EMKR)

January 9, 2017 0

After a stellar end to 2016 for chip stocks it’s easy to believe the rally is a bit long in the tooth. While these stocks have historically higher beta than the rest of the market, they’re not exactly at the cornerstone of the post-Election Trump rally. In fact, lots of these companies could be threatened under the new administration’s policies, especially if anything resembling a trade war with China develops […]

Stock Analysts

Nordson’s ACE Buyout to Boost Advanced Technology Sales

January 9, 2017 0

Precision dispensing equipment manufacturer Nordson Corporation NDSN recently announced that it has acquired Spokane, WA-based ACE Production Technologies, Inc. Financial terms of the transaction were kept under wraps. Post the release of fourth-quarter fiscal 2016 (ended Oct 31, 2016) results on Dec 14, 2016, shares of Nordson Corporation yielded a positive 1.4% return, outperforming the negative return of 0.6% generated by the Zacks categorized Machinery General Industrial industry […]

Stock Analysts

Pfizer’s Humira Biosimilar Meets Primary Endpoint in Study (Revised)

January 9, 2017 0

Pfizer, Inc. PFE announced positive top-line results from the comparative REFLECTIONS B538-02 study on its investigational compound, PF-06410293, a potential biosimilar to AbbVie Inc.’s ABBV Humira (adalimumab) approved for the treatment of patients with rheumatoid arthritis. Pfizer’s three-month share price movement shows that the stock has outperformed the Zacks classified Large Cap Pharma industry. […]

Stock Analysts

Albemarle Gets Final Approval for Lithium Expansion in Chile

January 9, 2017 0

Specialty chemicals maker Albemarle ALB recently agreed to amend its lithium production rights agreement with the Chilean Economic Development Agency, effective Dec 30, 2016, to extend the term of the deal and increase the company's authorized lithium quota at its facility in the Salar de Atacama, Chile. The company noted that the terms of the amendment have been fully approved by all applicable Chilean authorities, including the Comptroller General and the Nuclear Energy Commission. […]

Mergers & Acquisitions

One Equity Partners Completes Acquisition of Anvil International, LLC

January 9, 2017 0

One Equity Partners Completes Acquisition of Anvil International, LLC Corporate Carve-out of Market Leader PR Newswire NEW YORK, Jan. 9, 2017 NEW YORK , Jan. 9, 2017 /PRNewswire/ — One Equity Partners, a middle market private equity firm, today announced that it has signed a definitive agreement for the acquisition of Anvil International (“Anvil”), a leading North American manufacturer of high quality pipe fittings and system components, from Mueller Water Products (NYSE: MWA). […]

Mergers & Acquisitions

Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform

January 9, 2017 0

Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform PR Newswire WINDSOR, England, January 9, 2017 WINDSOR, England , January 9, 2017 /PRNewswire/ — Macrophage Pharma Limited , a newly formed immune-oncology company, today announced that it has successfully raised £9 million in a Series A equity financing round. The Company has also acquired global rights to a novel technology platform, Esterase Sensitive Motif (ESM), from Chroma Therapeutics Limited ( Oxford, UK ) together with discovery stage therapeutic assets. […]